Although high-dose vitamin C could potentially be effective in treating patients with KRAS mutated cancers, it is unlikely that this treatment, when used as a monotherapy, would be sufficient to target the molecular heterogeneity and multiple escape mechanisms of these tumors16. Here, KRAS is linked to cancer.